From: Cost-effectiveness of fenofibrate for preventing diabetic complications in Australia
Mean | |
---|---|
Age | 61 |
Female, % | 45.9 |
BMI | 33.6 |
Duration of diabetes | 12.4 |
Smoker, % | 14.7 |
HbA1c, % | 8.4 |
Systolic blood pressure, mmHg | 132 |
HDL, mmol/L | 1.3 |
LDL, mmol/L | 3 |
Haemoglobin, g/dl | 14.4 |
Heart rate, beats/min | 78.6 |
White blood cell count | 7 |
Estimated glomerular filtration rate, ml/min/1.73m2 | 74.2 |
History of atrial fibrillation, % | 5.4 |
History of peripheral vascular disease, % | 8.4 |
History of renal failure, % | 4.5 |
Blindness, % | 1.9 |
Albuminuria (micro or macro), % | 26.7 |
History of Ulcer, % | 6.3 |
History of amputation, % | 2.3 |
History of IHD, % | 3.2 |
History of MI, % | 9.5 |
History of stroke, % | 15.1 |
History of CHF, % | 14.3 |